Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Moss

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Blood|January 28, 1999
Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonismS R Burrows, R Khanna, D J Moss
International Journal of Cancer|May 15, 1979
Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte culturesA B Rickinson, D J Moss, J H Pope
International Journal of Cancer|May 15, 1984
Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virusD J Moss, S R Burrows, P G Parsons
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virusI S Misko, D J Moss, J H Pope
International Journal of Cancer|January 15, 1972
Identity of the soluble EBV-associated antigens of human lymphoid cell linesB M Reedman, J H Pope, D J Moss
International Journal of Cancer|May 15, 1979
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte culturesD J Moss, A B Rickinson, J H Pope
European Journal of Cell Biology|June 1, 1993
Substrate-bound GP130/F11 will promote neurite outgrowth: evidence for a cell surface receptorG A Clarke, C A White, D J Moss
International Journal of Cancer|December 1, 1978
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytesD J Moss, A B Rickinson, J H Pope
Journal of Virology|June 1, 1986
Induction of Epstein-Barr virus nuclear antigensD J Moss, T B Sculley, J H Pope
Vaccine|June 8, 2001
Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine designM Bharadwaj, M Sherritt, R Khanna, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Blood|January 28, 1999
Direct alloreactivity by human cytotoxic T lymphocytes can Be inhibited by altered peptide ligand antagonismS R Burrows, R Khanna, D J Moss
International Journal of Cancer|May 15, 1979
Long-term C-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte culturesA B Rickinson, D J Moss, J H Pope
International Journal of Cancer|May 15, 1984
Calcium concentration defines two stages in transformation of lymphocytes by Epstein-Barr virusD J Moss, S R Burrows, P G Parsons
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1980
HLA antigen-related restriction of T lymphocyte cytotoxicity to Epstein-Barr virusI S Misko, D J Moss, J H Pope
International Journal of Cancer|January 15, 1972
Identity of the soluble EBV-associated antigens of human lymphoid cell linesB M Reedman, J H Pope, D J Moss
International Journal of Cancer|May 15, 1979
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte culturesD J Moss, A B Rickinson, J H Pope
European Journal of Cell Biology|June 1, 1993
Substrate-bound GP130/F11 will promote neurite outgrowth: evidence for a cell surface receptorG A Clarke, C A White, D J Moss
International Journal of Cancer|December 1, 1978
Long-term T-cell-mediated immunity to Epstein-Barr virus in man. I. Complete regression of virus-induced transformation in cultures of seropositive donor leukocytesD J Moss, A B Rickinson, J H Pope
Journal of Virology|June 1, 1986
Induction of Epstein-Barr virus nuclear antigensD J Moss, T B Sculley, J H Pope
Vaccine|June 8, 2001
Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine designM Bharadwaj, M Sherritt, R Khanna, et al.
Pageof 18